PORTO, Portugal, January 27, 2026--(BUSINESS WIRE)--Bial, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that 75% of patients currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results